The growth and the control of human immunodeficiency virus in the lung: Implications for highly active antiretroviral therapy

European Journal of Clinical Investigation

Volumn 29, Issue 11, 1999, Pages 964-972

  White, N C ^a   Agostini, C ^b   Israel Biet, D ^c   Semenzato, G ^b   Clarke, J R ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^c Hopital Laennec   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYTOKINE; DIDANOSINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; GENERAL ASPECTS OF DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; LUNG INFECTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; LUNG; PNEUMONIA, PNEUMOCYSTIS; TUBERCULOSIS, PULMONARY;

EID: 0032754522     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00550.x     Document Type: Review

References (66)

1. 1 Agostini C, Zambello R, Trentin L, Semenzato G. HIV and pulmonary immune responses. Immunol Today 1996; 17: 359-64.
2. 2 Agostini C, Adami V, Poulter LW, Israel-Biet D, Freitas E Costa M, Cipriani A, et al. Role of bronchoalveolar lavage in predicting survival of patients with HIV-1 infection. Am J Respir Crit Care Med 1997; 156: 1501-7.
3. 3 Pinkston P, Pelletier N, Arena C, Schock J, Garland R, Rose RM, Quantitative culture of HIV-1 from bronchoalveolar lavage cells. Am J Resp Crit Care Med 1995; 152: 254-9.
4. 4 Clarke JR, Gates AJ, Coker RT, Douglass JA, Williamson JD, Mitchell DM. HIV-1 proviral DNA copy number in peripheral blood leucocytes and bronchoalveolar lavage cells of AIDS patients. Clin Exp Immunol 1994; 96: 182-6.
5. 5 Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Human immunodeficiency virus type 1 env and p17 gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. J Infect Dis 1995; 171: 797-804.
6. 6 Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and bronchoalveolar lavage cells of AIDS patients. AIDS 1998; 12: 719-27.
7. 7 Van't wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schuitemaker H. Analysis of the temporal relationship between HIV-1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 1998; 72: 488-96.
8. 8 Clarke JR, Robinson DS, Coker RJ, Miller RF, Mitchell DM. Role of the Human Immunodeficiency virus within the lung. Thorax 1994; 50: 567-76.
9. 9 Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin J-F. HIV in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Resp Cell Mol Biol 1994; 10: 72-8.
10. 10 Chayt KJ, Harper ME, Marselle LM, Lewin EB, Rose RM, Oleske JM, et al. Detection of HTLV III DNA in lungs of patients with AIDS and pulmonary involvement. JAMA 1986; 256: 2356-9.
11. 11 Clarke JR, Williamson JD, Mitchell DM. Comparative study of the isolation of human immunodeficiency virus from the lung and peripheral blood of AIDS patients. J Med Virol 1993; 39: 196-9.
12. 12 Nakata K, Weiden M, Harkin T, Ho D, Rom WN. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1 infected patients: Evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1995; 1: 744-57.
13. 13 Semenzato G, Agostini C, Ometto L, Zamhello R, Trentin L, Chieco-Bianchi L, et al. CD8+ lymphocytes in the lung of acquired immunodeficiency syndrome patients harbour human immunodeficiency virus type 1. Blood 1995; 85: 2308-23.
14. 14 Semenzato G, Agostini C, Chieco-Bianchi L, DeRossi A. Frequent infection of. CD8-positive T lymphocytes with HIV-1. J Leukoc Biol 1998; 64: 298-301.
15. + cytolytic T lymphocytes become infected in vitro in the process of killing HIV-1-infected target cells. Eur J Immunol 1994; 24: 531-7.
16. 16 Pearce TE, Nowakowski M, Eden E, et al. Uniform detection of HIV-1 in alveolar macrophages of pediatric but not adult AIDS patients. J Leukoc Biol 1993; 53: 722-62.
17. 17 Landay AL, Schade SZ, Takefman DM, Kuhns MC, McNamara AL, Rosen RL, et al. Detection of HIV-1 provirus in bronchoalveolar lavage cells by polymerase chain reaction. J AIDS 1993; 6: 171-5.
18. 18 Clarke JR, Fleming J, Nukuna A, Williamson JD, Mitchell DM. The epidemiology of HIV-1 infection in the lung of AIDS patients. AIDS 1993; 7: 555-60.
19. 19 Rose RM, Krivine A, Pinkston P, Gillis JM, Huang A, Hammer SM. Frequent Identification of HIV-1 DNA in bronchoalveolar lavage cells obtained from individuals with the acquired immunodeficiency syndrome. Am Rev Resp Dis 1991; 143: 850-4.
20. 20 Dean NC, Golden JA, Evans LA, Warnock ML, Addison TE, Hopewell PC, et al. Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS. Chest 1988; 93: 1176-9.
21. 21 Jeffrey A, Israel-Biet D, Andrieu JM, Even P, Venet A. HIV isolation from bronchoalveolar lavage (BAL) derived pulmonary cells. Clin Exp Immunol 1991; 85: 488-92.
22. 22 Nakata K, Rom WN, Honda Y, Condos R, Kanegasaki S, Cao Y, et al. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Resp Crit Care Med 1997; 155: 996-1003.
23. 23 Clarke JR, Israel-Biet D. Interactions between opportunistic micro-organisms and HIV in the lung. Thorax 1996; 51: 875 7.
24. 24 Clarke JR, Mitchell D, Coker R, Israel-Biet D. Is the lung important as a privileged site for the human immunodeficiency virus? Thorax 1998; 53: 81-2.
25. 25 Sierra-Madero JG, Tossi Z, Hom DL, Finegan CK, Hocnig E, Rich EA. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1 infected persons: Production of cytokines and clinical status. J Infect Dis 1994; 168: 18-27.
26. 26 Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science 1997; 276: 1857-61.
27. 27 Israel-Biet D, Cadranel J, Even P. Human immunodeficiency virus production by alveolar lymphocytes is increased during Pneumocystis carinii pneumonia. Am Rev Respir Dis 1993; 148: 1302-12.
28. 28 Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, Digioia RA, Sanchez WC, et al. Cigarette smoking: a modifier of HIV-1 infection? J AIDS 1991; 4: 76-83.
29. 29 Abbud RA, Finegan CK, Guay LA, Rich EA. Enhanced production of human immunodeficiency virus type 1 by in vitro infected alveolar macrophages from otherwise healthy cigarette smokers. J Infect Dis 1995; 172: 859-63.
30. 30 Nieman RB, Fleming J, Coker RJ, Harris JR, Mitchell DM. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993; 7: 705-10.
31. 31 Lu W, Israel-Biet D. Virion concentration in bronchoalveolar lavage fluids of HIV infected patients. Lancet 1993; 342: 298.
32. 32 Alimohammadi A, Coker R, Miller R, Mitchell D, Williamson J, Clarke JR. Genotypic variants of HIV-1 from peripheral blood and lungs of AIDS patients. J AIDS 1997; 11: 831-2.
33. 33 Hughes ES, Bell JE, Simmonds P. Investigation of the dynamics of the spread of HIV to brain and other tissues by evolutionary analysis of sequences from p17 gag and env genes. J Virol 1997; 72: 1272-80.
34. 34 Itescu S, Simonelli PF, Winchester RJ, Ginsberg HS. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc Natl Acad Sci USA 1994; 91: 11378-82.
35. 35 Hughes ES, Bell JE, Simmonds P. Investigation of population diversity of HIV-1 in vivo by nucleotide sequencing and length polymorphism analysis of the V1/V2 hypervariable region of env. J Gen Virol 1997; 78: 2871-82.
36. 36 Ait-Khaled M, McLaughlin JE, Johnson MA, Emery VC. Distinct HIV-1 long terminal repeat quasispecies present in nervous tissue compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 1995; 9: 675-83.
37. 37 Canque B, Rosenzwajg Gey A, Tartour E, Fridman WH, Gluckman JC. Macrophage inflammatory protein 1 alpha is induced by human immunodeficiency virus infection of monocyte derived macrophages. Blood 1996; 87: 2011-9.
38. 38 Lipman MCI, Johnson MA, Poulter LW. Functionally relevant changes occur in HIV infected individuals' alveolar macrophages prior to the onset of respiratory disease. AIDS 1997; 11: 765-72.
39. 39 Contini C, Paoletti F, Cultrera R, Angelici E. Similar tumour necrosis factor alpha concentrations in bronchoalveolar lavage macrophages from HIV infected patients with or without Pneumocystis carinii pneumonia. Immunol Infect Dis 1995; 5: 123-6.
40. 40 Twigg HL, Spain BA, Soliman DM, Bowen LK, Heidler KM, Wilkes DS. Impaired IgG production in the lungs of HIV infected individuals. Cell Immunol 1996; 170: 127-33.
41. 41 Akridge RE, Oyafuso LKM, Reed SG. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994; 153: 5782-9.
42. 42 Agostini C, Zambello R, Trentin L, Cerutti A, Enthammer C, Facco M, et al. Expression of TNF receptor by T cells and membrane TNF alpha by alveolar macrophages suggests a role for TNF alpha in the regulation of the local immune responses in the lung of HIV-1 infected patients. J Immunol 1995; 154: 2928-38.
43. 43 Israel-Biet D, Cadranel J, Beldjord K, Andrieu M, Jeffrey A, Even P. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991; 147: 490-4.
44. 44 Spain BA, Soliman DM, Sidner RA, Twigg HL. Enhanced proliferation and IL-2 secretion by lung lymphocytes from HIV-1 infected patients. Am J Physiol 1995; 13: L498-L506.
45. 45 Agostini C, Trentin L, Zambello R, Bulian P, Caenazzo C, Cipriani A, et al. Release of GM-CSF by alveolar macrophages in the lung of HIV-1 infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992; 149: 3379-85.
46. 46 Agostini C, Trentin L, Sancetta R, Facco M, Tassinari C, Cerutti A, et al. IL-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with AIDS. Blood 1997; 89: 1115-23.
47. 47 Denis M, Ghandirian E. Dysregulation of Interleukin 8, Interleukin 10 and Interleukin 12 release by alveolar macrophages from HIV type 1 infected individuals. AIDS HR 1994; 10: 1619-27.
48. 48 Denis M, Ghandirian E. Interaction between myobacterium avium and human immunodeficiency virus (HIV) in bronchoalveolar macrophages of normal and infected individuals. Am J Resp Cell Mol Bio 1994; 11: 486-95.
49. 49 Perenboom RM, Sauerwein RW, Beekers P, Van Schijindel ACHW, Van Steenwijk RP, Borleffs JJC et al. Cytokine profiles in bronchoalveolar lavage fluid and blood in HIV seropositive patients with Pnemocystis carinii pneumonia. Eur J Clin Invest 1997; 27: 333-9.
50. 50 Kandil O, Fishman JA, Koziel H, Pinkston P, Rose RM, Remold HG. Human Immunodeficiency Virus type-1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994; 62: 644-50.
51. 51 Garrait V, Cadranel J, Esvant H, Herry I, Morinet P, Mayaud C, et al. Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol 1997; 159: 2824-30.
52. 52 Denis M, Ghadirian E. Interleukin-13 and interleukin-4 protect bronchoalveolar macrophages from productive infection with HIV-1. AIDS Res Hum Retrov 1994; 10: 795-802.
53. 53 Naif Hm Chang J, Ho Shon M, Li S, Cunningham AL. Inhibition of human immunodeficiency virus replication in differentiating monocytcs by interleukin 10 occurs in parallel with inhibition of cellular RNA expression. AIDS Res Hum Retrov 1996; 12: 1237-45.
54. 54 Agostini C, Zambello R, Facco M, Perin A, Piazza F, Siviero M, et al. T-cell infiltration in extravascular tissues of patients with HIV infection. IL-15 up-modulates costimulatory pathways involved in the APC-T cell interaction. Blood 93: 1277-86.
55. 55 Rogge L, Papi A, Presky DH, Biffi M, Minetti LJ, Miotti D, et al. Antibodies to the IL-12 receptor-β2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol 1999; 162: in press.
56. 56 Ullum H, Lepri AC, Victor J, Aladdin H, Phillips AN, Gerstoft J, et al. Production of beta-chemokines in human immunodeficiency virus infection: evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J Infect Dis 1998; 177: 331-6.
57. + alveolitis. Clin Exp Immunol 1994; 96: 187-92.
58. 58 Simmons G, Clapham GJ, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 1997; 276: 276-9.
59. 59 Coffey MJ, Woffendin C, Phare SM, Strieter RM, Markovitz DM. RANTES inhibits HIV-1 replication in human peripheral blood mononuclear cells and alveolar macrophages. Am J Physiol 1997; 272: L1025-9.
60. 60 Jansson M, Popovic M, Karlsson A, Cocchi F, Rossi P, Albert J, et al. Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. Proc Natl Acad Sci USA 1996; 93: 15382-7.
61. 61 Hammer SM, Gillis JM, Pinkston P, Rose RM. Effect of zidovudine and granulocyte macrophage stimulating factor on HIV replication in alveolar macrophages. Blood 1990; 75: 1215-9.
62. 62 Richman DD, Kornbluth RS, Carson DA. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages. J Exp Med 1987; 166; 1144-9.
63. 63 Cavert W, Nortermans DW, Stakus K, Wietgrefe SW, Zupancic M, Gebhard K, et al. Kinetics of response in lymphoid tissue to antiretroviral therapy of HIV-1 infection. Science 1997; 276: 960-4.
64. 64 Aquaro S, Calio R, Balestra E, Bagnerelli P, Cenci A, Bertoli A, et al. Clinical implications of HIV dynamics and drug resistance in macrophages. J Biol Regul Homoest Ag 1998; 12: 23-7.
65. 65 Gates A, Coker R, Miller R, Mitchell D, Williamson J, Clarke JR. Zidovudine resistant variants of HIV-1 in the lung. AIDS 1997; 11: 702-3.
66. 66 Atkins M, Strappe P, Kaye P, Kaye S, Loveday C, McLaughlin JE, et al. Quantitative differences in the distribution of Zidovudine resistance mutations in multiple post-mortem tissues from AIDS patients. J Med Virol 1998; 55: 138-46.